Global Oncology Information Systems Market

Oncology Information Systems Market Size, Share, Growth Analysis, By Application (Medical Oncology, Surgical Oncology), By Product & Services (Software, Solutions), By End User (Hospitals & Diagnostic Imaging Centers), By Region -Industry Forecast 2026-2033

Report ID: SQMIG35A2458 | Region: Global | Published Date: December, 2025
Pages: 219 | Tables: 90 | Figures: 76

Share your requirements to help us to customize the report.
   I acknowledge that I have read the Privacy Policy
Confidentiality

We respect your privacy rights and safeguard your personal information. We prevent the disclosure of personal information to third parties.

Our Clients

  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt
  • Schineder Electric
  • KSIA - Korea Semiconductor Industry Association
  • Hitachi Astemo Limited
  • Samsung Electronics
  • Halvo holdings
  • NTT corporation
  • AGC Inc
  • Siemens AG
  • Unilever
  • Merck Pharmaceuticals
  • Atlas Copco
  • Hologic - Medical Technology company
  • Novartis
  • Henkel
  • Reckitt

    • FAQs

    Global Oncology Information Systems Market size was valued at USD 7.78 Billion in 2024 and is poised to grow from USD 8.39 Billion in 2025 to USD 15.42 Billion by 2033, growing at a CAGR of 7.9% during the forecast period (2026–2033). 

    The oncology information systems market is marked by fierce competition, with key players focusing on innovations, partnerships and strategic acquisitions to strengthen their market position. Leading companies using advanced technologies such as artificial intelligence (AI), machine learning and cloud computing to enhance their solutions. These companies aim to provide advanced platforms that seamlessly integrate with existing healthcare IT infrastructure, ensuring better patient care and efficiency.  'Elekta AB (Sweden) ', 'McKesson Corporation (United States) ', 'Siemens Healthineers (Germany) ', 'Epic Systems Corporation (United States) ', 'IBM Corporation (United States) ', 'Cerner Corporation (United States) ', 'Advanced Data Systems Corporation (United States) ', 'F. Hoffmann-La Roche AG (Switzerland) ', 'AmerisourceBergen Corporation (United States) ', 'General Electric Company (United States) ', 'Accuray Incorporated (United States) ', 'Optum, Inc. (United States) ', 'Allscripts Healthcare Solutions, Inc. (United States) ', 'MICA Information Systems, Inc. (United States) ', 'CureMD Healthcare (United States) ', 'EndoSoft LLC (United States) ', 'RaySearch Laboratories AB (Sweden) ', 'Altos Solutions (United States) ', 'Flatiron Health (United States) ', 'Bogardus Medical Systems (United States)'

    Increasing cancer burden across the globe is a major driver for the oncology information systems market. According to the World Health Organization (WHO), cancer is one of the leading causes of death worldwide, requiring effective solutions for treatment planning, data management and patient care. OIS systems for oncology departments are facilitated by the sharing of real-time information, which improves the accuracy of treatment and improving patient outcomes is further reinforced by drugs. 

    Integration of Artificial Intelligence in OIS :A key oncology information systems market trend is the integration of artificial intelligence (AI) to improve treatment accuracy and efficiency. AI-powered systems are able to analyze large data sets to identify patterns and predict how patients will respond to treatments. This integration not only reduces human error, but also speeds up decision making, especially in complex cases. Companies are investing in AI-powered modules to give OIS a competitive advantage and meet the growing demand for advanced oncology care.  

    As per oncology information systems market outlook, the North America regional market accounted for the largest revenue share at 38.3% in 2023. The major factors driving this growth were availability of advanced healthcare infrastructure, increased awareness in patient data management in the region. The increasing adoption of OIS to track and record treatment results of cancer patients and the rising importance of EMR for making better treatment decisions are expected to boost the regional market growth. The increasing importance of treatment regimen monitoring, dosing and treatment planning is also expected to increase the demand for OIS in this region. 

    Related Reports

    Oncology Market
    Buy Now GET FREE SAMPLE
    Oncology Drugs Market
    Buy Now GET FREE SAMPLE
    Healthcare Information Systems Market
    Buy Now GET FREE SAMPLE
    Non Clinical Information System Market
    Buy Now GET FREE SAMPLE
    Veterinary Oncology Market
    Buy Now GET FREE SAMPLE
    Companion Diagnostics for Oncology Market
    Buy Now GET FREE SAMPLE
    Clinical Decision Support System Market
    Buy Now GET FREE SAMPLE
    Clinical Oncology Next Generation Sequencing Market
    Buy Now GET FREE SAMPLE

    Feedback From Our Clients

    Global Oncology Information Systems Market

    Report ID: SQMIG35A2458

    $5,300
    BUY NOW GET FREE SAMPLE